Medicamen Biotech Limited (MEDICAMEQ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medicamen Biotech Limited (MEDICAMEQ) has a cash flow conversion efficiency ratio of 0.018x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs36.46 Million ≈ $394.32K USD) by net assets (Rs2.00 Billion ≈ $21.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MEDICAMEQ net asset quality index to measure how much of total assets are equity-financed.
Medicamen Biotech Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Medicamen Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Medicamen Biotech Limited (MEDICAMEQ) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Medicamen Biotech Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medicamen Biotech Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wisr Ltd
AU:WZR
|
0.105x |
|
PetVivo Holdings Inc
NASDAQ:PETV
|
-0.438x |
|
Seafresh Industry Public Company Limited
BK:CFRESH
|
0.070x |
|
Cemat A/S
CO:CEMAT
|
0.066x |
|
Big Camera Corporation Public Company Limited
BK:BIG
|
-0.016x |
|
Tracxn Technologies Limited
NSE:TRACXN
|
0.019x |
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
0.267x |
|
5TH PLANET GAMES DK -50
F:2HG1
|
-0.012x |
Annual Cash Flow Conversion Efficiency for Medicamen Biotech Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Medicamen Biotech Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Medicamen Biotech Limited market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs2.13 Billion ≈ $23.01 Million |
Rs-98.59 Million ≈ $-1.07 Million |
-0.046x | -42.21% |
| 2024-03-31 | Rs2.07 Billion ≈ $22.38 Million |
Rs-67.44 Million ≈ $-729.32K |
-0.033x | -0.14% |
| 2023-03-31 | Rs1.93 Billion ≈ $20.92 Million |
Rs-62.93 Million ≈ $-680.54K |
-0.033x | -215.97% |
| 2022-03-31 | Rs1.46 Billion ≈ $15.84 Million |
Rs41.09 Million ≈ $444.38K |
0.028x | -70.81% |
| 2021-03-31 | Rs1.33 Billion ≈ $14.37 Million |
Rs127.72 Million ≈ $1.38 Million |
0.096x | -9.00% |
| 2020-03-31 | Rs1.21 Billion ≈ $13.11 Million |
Rs128.02 Million ≈ $1.38 Million |
0.106x | +112.74% |
| 2019-03-31 | Rs866.34 Million ≈ $9.37 Million |
Rs43.01 Million ≈ $465.12K |
0.050x | +167.91% |
| 2018-03-31 | Rs746.08 Million ≈ $8.07 Million |
Rs-54.54 Million ≈ $-589.80K |
-0.073x | -154.50% |
| 2017-03-31 | Rs267.81 Million ≈ $2.90 Million |
Rs35.92 Million ≈ $388.49K |
0.134x | -61.29% |
| 2016-03-31 | Rs179.09 Million ≈ $1.94 Million |
Rs62.06 Million ≈ $671.13K |
0.347x | +281.86% |
| 2015-03-31 | Rs171.85 Million ≈ $1.86 Million |
Rs-32.74 Million ≈ $-354.11K |
-0.191x | -161.32% |
| 2014-03-31 | Rs165.38 Million ≈ $1.79 Million |
Rs51.39 Million ≈ $555.74K |
0.311x | +410.42% |
| 2013-03-31 | Rs157.17 Million ≈ $1.70 Million |
Rs-15.73 Million ≈ $-170.14K |
-0.100x | +42.34% |
| 2012-03-31 | Rs201.01 Million ≈ $2.17 Million |
Rs-34.90 Million ≈ $-377.38K |
-0.174x | -131.21% |
| 2011-03-31 | Rs204.12 Million ≈ $2.21 Million |
Rs113.52 Million ≈ $1.23 Million |
0.556x | +722.44% |
| 2010-03-31 | Rs162.61 Million ≈ $1.76 Million |
Rs11.00 Million ≈ $118.92K |
0.068x | -89.45% |
| 2009-03-31 | Rs129.60 Million ≈ $1.40 Million |
Rs83.07 Million ≈ $898.33K |
0.641x | +227.09% |
| 2008-03-31 | Rs115.83 Million ≈ $1.25 Million |
Rs22.70 Million ≈ $245.46K |
0.196x | +662.67% |
| 2007-03-31 | Rs100.73 Million ≈ $1.09 Million |
Rs2.59 Million ≈ $27.99K |
0.026x | -91.54% |
| 2006-03-31 | Rs85.67 Million ≈ $926.49K |
Rs26.02 Million ≈ $281.45K |
0.304x | -- |
About Medicamen Biotech Limited
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-… Read more